ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2749

Long Non-coding RNA HOTAIR Induces Myofibroblast Activation in Systemic Sclerosis Through EZH2 Dependent De-repression of NOTCH Signalling Pathway Activation

Christopher Wasson1, Giuseppina Abignano 2, Rebecca Ross 3, Heidi Hermes 4, Sergio Jimenez 5 and Francesco Del Galdo 6, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 23Rheumatology Institute of Lucania (IReL) and University of Leeds, Leeds, United Kingdom, 3Univesristy of Leeds, Leeds, England, United Kingdom, 4Jefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, 5Jefferson Institute of Molecular Medicine and Division of Connective Tissue Diseases, Thomas Jefferson University, Philadelphia, PA, Philadelphia, PA, 6University of Leeds and LTHT NIHR Biomedical Research Centre, Leeds, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: systemic sclerosis and epigenetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T095: Systemic Sclerosis & Related Disorder – Basic Science (2744–2749)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Fibroblasts explanted from affected tissues in Systemic Sclerosis (SSc), conserve their pro-fibrotic phenotype characterised by increased secretion of collagens and other extracellular matrix proteins and comprise a large proportion of a-Smooth Muscle Actin (a-SMA) positive myofibroblasts. Long non-coding RNAs (lncRNAs) within the HOX loci have been described as master epigenetic regulators within the connective tissue. Specifically, HOTAIR has been shown to drive the specific phenotype of the hands and feet which are also the first body regions affected by SSc. Here we aimed to unravel the mechanisms responsible for the epigenetically stable activation of SSc fibroblasts

Methods: Full thickness skin biopsies were surgically obtained from the forearms oftwelve adult patients with SSc of recent onset. Fibroblasts were isolated and cultured in monolayers and protein and RNA extracted from the fibroblast cultures. Laser capture was performed to isolate cells expressing or not a-SMA as a marker of myofibroblast differentiation. HOTAIR was expressed in healthy dermal fibroblasts by lentiviral induction employing a vector containing the specific sequence. Gamma secretase inhibitors RO4929097 and DAPT were employed to block Notch signalling in SSc fibroblasts. EZH2 was blocked in SSc fibroblasts with the specific inhibitor GSK126. 

Results: HOTAIR expression was increased in SSc patients’ skin (100 fold) and in SSc explanted fibroblasts (5 fold). These results were highly significant (p< 0.001 for both). Further, laser captured a-SMA expressing myofibroblasts expressed in average 2.5 fold greater HOTAIR RNA levels compared to a -SMA negative cells from the same donors (P< 0.05). In vitro, we demonstrated that lentiviral induced stable overexpression of HOTAIR in healthy dermal fibroblasts led to their profibrotic activation, including significantly increased expression of Col1A1 and a-SMA both at mRNA and protein levels (2.8 and 1.8 fold respectively, p< 0.05). We further showed that HOTAIR-induced profibrotic activation was due to EZH2 dependent spread of H3k27me3 methylation marker, as demonstrated by complete inhibition by treatment with GSK126. Additionally, we showed that EZH2 led to profibrotic activation by decreasing the expression of miRNA 34a. The reduced miRNA 34a levels in turn led to NOTCH increased expression and signalling pathway activation. Consistent with these findings, treatment of the HOTAIR expressing cells with two different types of gamma secretase inhibitors known to block NOTCH activation, normalised a-SMA expression and suppressed collagen production by 50%. Importantly, treatment with the EZH2 inhibitor GSK126 suppressed collagen production in the HOTAIR expressing cells and SSc fibroblasts by 30% and 50% respectively (p< 0.05) and normalised a-SMA levels in both cell lines to control levels (p< 0.05).

Conclusion: Here we show that the epigenetically stable activation of SSc dermal fibroblasts is due to HOTAIR led EZH2 dependent de-repression of NOTCH signalling. The results of these studies identify a new venue to modulate fibroblasts biology which could inform clinical research to resolve chronic fibrosis and re-establish tissue homeostasis in SSc.


Disclosure: C. Wasson, None; G. Abignano, None; R. Ross, None; H. Hermes, None; S. Jimenez, None; F. Del Galdo, AstraZeneca, 5, 8, GSK, 5, 8, Boehringer-Ingelheim, 5, 8, Actelion, 5, 8, Capella Biosciences, 2, 5, Chemomab, 2, 5.

To cite this abstract in AMA style:

Wasson C, Abignano G, Ross R, Hermes H, Jimenez S, Del Galdo F. Long Non-coding RNA HOTAIR Induces Myofibroblast Activation in Systemic Sclerosis Through EZH2 Dependent De-repression of NOTCH Signalling Pathway Activation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/long-non-coding-rna-hotair-induces-myofibroblast-activation-in-systemic-sclerosis-through-ezh2-dependent-de-repression-of-notch-signalling-pathway-activation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-non-coding-rna-hotair-induces-myofibroblast-activation-in-systemic-sclerosis-through-ezh2-dependent-de-repression-of-notch-signalling-pathway-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology